You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amyloid-beta therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Predicting Cognitive Decline From Androgen Deprivation Therapy

Not yet recruiting
  • Prostate Cancer
  • Blood-based assay
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Apr 20, 2023

Insomnia Trial in Kansas City (Cognitive Behavioral Therapy for Insomnia (CBT-I), Sleep and Lifestyle Education)

Recruiting
  • Insomnia
  • Cognitive Behavioral Therapy for Insomnia (CBT-I)
  • Sleep and Lifestyle Education
  • Kansas City, Kansas
    University of Kansas Medical Center- Sleep, Health and Wellness
Nov 1, 2022

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Recruiting
  • Alzheimer Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 7, 2023

[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

Recruiting
  • Alzheimer's Disease
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023

Hypertension Trial in Dallas (Standard Care, Intensive Treatment)

Active, not recruiting
  • Hypertension
  • Standard Care
  • Intensive Treatment
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 11, 2022

Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)

Recruiting
  • Alzheimer Disease
  • Lemborexant 25 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 16, 2023

Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)

Not yet recruiting
  • Bioavailability
  • +2 more
  • Low curcumin group
  • High curcumin group
  • Lubbock, Texas
    Texas Tech University Health Sciences Center
Mar 15, 2023

Mild Cognitive Impairment Trial in San Francisco (Transcranial alternating current stimulation)

Completed
  • Mild Cognitive Impairment
  • Transcranial alternating current stimulation
  • San Francisco, California
    University of California, San Francisco
Aug 2, 2022

Alzheimer Trial (ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo)

Not yet recruiting
  • Alzheimer Disease
  • ALZN002 (autologous DCs pulsed with E22W mutant peptide).
  • Placebo
  • (no location specified)
Apr 17, 2023

Normal Physiology Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) ([18F]florbetaben)

Completed
  • Normal Physiology
  • [18F]florbetaben
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Alzheimer Trial in United States (AV-1959D, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • AV-1959D
  • Placebo
  • Phoenix, Arizona
  • +5 more
Dec 22, 2022

Amyloid in Blood and Imaging Related to Dementia

Recruiting
  • Alzheimer Disease
  • Alzheimer Dementia
  • Blood collection, PiB PET/MRI, and cognitive testing
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 30, 2021

Alzheimer's Disease Trial in Fuzhou (18F-92)

Recruiting
  • Alzheimer's Disease
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Nov 23, 2021

Transfusion-dependent Beta-thalassemia After Gene Therapy

Recruiting
  • Transfusion-dependent Beta-Thalassemia
  • Gene Therapy
  • Gene therapy
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 6, 2023

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

Alzheimer Trial in Göttingen, Mannheim (TEP)

Completed
  • Alzheimer Disease
  • Göttingen, Germany
  • +1 more
Mar 29, 2022

Alzheimer Trial in New York, Philadelphia (CT1812, Placebo)

Completed
  • Alzheimer Disease
  • New York, New York
  • +1 more
Jan 10, 2022

Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)

Active, not recruiting
  • Beta Thalassaemia
  • Safety and Efficacy assessments
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022

Postoperative Cognitive Dysfunction Trial in San Francisco (Florbetapir F 18 (18F-AV-45), no intervention)

Recruiting
  • Postoperative Cognitive Dysfunction
  • Florbetapir F 18 (18F-AV-45)
  • no intervention
  • San Francisco, California
    San Francisco VA Medical Center
Jul 6, 2021

Alzheimer, Late Onset, Mild Cognitive Impairment, Sleep Trial in Pittsburgh (Time in Bed Restriction, Sleep Schedule)

Recruiting
  • Alzheimer Disease, Late Onset
  • +4 more
  • Time in Bed Restriction
  • Sleep Schedule
  • Pittsburgh, Pennsylvania
    UPMC Western Psychiatric Hospital
Oct 25, 2022

Cirrhosis, Decompensated Cirrhosis, Portal Hypertension Trial (EUS)

Not yet recruiting
  • Cirrhosis
  • +2 more
  • EUS
  • (no location specified)
Nov 13, 2022

Fabry Disease Trial in Taipei

Recruiting
  • Fabry Disease
    • Taipei, Taiwan
      Investigational Site Number :1580001
    Sep 24, 2023

    High-risk Neuroblastoma Trial in China (Dinutuximab Beta, 13 cis retinoic acid)

    Active, not recruiting
    • High-risk Neuroblastoma
    • Dinutuximab Beta
    • 13 cis retinoic acid
    • Beijing, Beijing, China
    • +3 more
    Dec 7, 2022

    Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,

    Active, not recruiting
    • Dilated Cardiomyopathies, Idiopathic
    • +3 more
    • Aurora, Colorado
    • +1 more
    Oct 31, 2022

    Gastric Varices Bleeding, Endoscopic Ultrasound Trial (EUS-Guided Therapy of Glue and Coil, Non-Selective Beta Blockers

    Not yet recruiting
    • Gastric Varices Bleeding
    • Endoscopic Ultrasound
    • EUS-Guided Therapy of Glue and Coil
    • Non-Selective Beta Blockers (Propanolol)
    • (no location specified)
    May 4, 2023